Evidence map›Paper›PMID 30674954›Full record

ArticleScientific reports2019

The E3 ubiquitin ligase Itch is required for B-cell development.

Xiaoling Liu, Yu Zhang, Yinxiang Wei, Zhiding Wang, Gaizhi Zhu, Ying Fang, Bing Zhai, Ruonan Xu, Gencheng Han, Guojiang Chen and 6 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. The Ubiquitin Ligase Itch Skews Light Zone Selection in Germinal Centers.Journal of immunology (Baltimore, Md. : 1950) · 2023
    Article
  7. Article
  8. TET2 Regulates 5-Hydroxymethylcytosine Signature and CD4Allergy, asthma & immunology research · 2022
    Article
  9. Article
  10. Article
  11. Review
  12. Gm6377 suppressed SP 2/0 xenograft tumor by down-regulating Myc transcription.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2020
    Article
  13. Review
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 6 institutions in 1 country.

Xiaoling LiuLaboratory of Immunology, Institute of Basic Medical Sciences, Beijing, 100850, China.
Yu ZhangLaboratory of Immunology, Institute of Basic Medical Sciences, Beijing, 100850, China.
Yinxiang WeiLaboratory of Immunology, Institute of Basic Medical Sciences, Beijing, 100850, China.
Zhiding WangLaboratory of Immunology, Institute of Basic Medical Sciences, Beijing, 100850, China.ORCID 0000-0001-8170-1359
Gaizhi ZhuLaboratory of Immunology, Institute of Basic Medical Sciences, Beijing, 100850, China.
Ying FangLaboratory of Immunology, Institute of Basic Medical Sciences, Beijing, 100850, China.
Bing ZhaiLaboratory of Immunology, Institute of Basic Medical Sciences, Beijing, 100850, China.
Ruonan XuLaboratory of Immunology, Institute of Basic Medical Sciences, Beijing, 100850, China.
Gencheng HanLaboratory of Immunology, Institute of Basic Medical Sciences, Beijing, 100850, China.
Guojiang ChenLaboratory of Immunology, Institute of Basic Medical Sciences, Beijing, 100850, China.
He XiaoLaboratory of Immunology, Institute of Basic Medical Sciences, Beijing, 100850, China.
Chunmei HouLaboratory of Immunology, Institute of Basic Medical Sciences, Beijing, 100850, China.
Beifen ShenLaboratory of Immunology, Institute of Basic Medical Sciences, Beijing, 100850, China.
Yan LiLaboratory of Immunology, Institute of Basic Medical Sciences, Beijing, 100850, China.
Ning MaDepartment of Rheumatology, First hospital of Jilin University, Changchun, 130021, China. britty1314@163.com.
Renxi WangLaboratory of Immunology, Institute of Basic Medical Sciences, Beijing, 100850, China. wang_renxi@yahoo.com.
Institute of Basic Medical Sciences of the Chinese Academy of Medical SciencesHenan University · CNJilin University · CN307th Hospital of Chinese People’s Liberation Army · CNCapital Medical University · CNChinese PLA General Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The E3 ubiquitin ligase Itch interacts with Foxo1 and targets it for ubiquitination and degradation during follicular helper T-cell differentiation, whereas the transcription factor Foxo1 plays a critical role in B-cell development. Thus, we proposed that Itch mediates B-cell differentiation. Unexpectedly, we found that Itch deficiency downregulated Foxo1 expression in B cells. Itch cKO (conditional knock out in B cells) mice had fewer pro-B cells in the bone marrow, more small resting IgM

Indexed as

AnimalsB-LymphocytesBone Marrow CellsCell DifferentiationForkhead Box Protein O1L-SelectinMiceMice, KnockoutMicroRNAsReceptors, Interleukin-7T-LymphocytesTranscription FactorsUbiquitin-Protein LigasesForkhead Box Protein O1Foxo1 protein, mouseItch protein, mouseJunB protein, mouseL-SelectinMicroRNAsMirn182 microRNA, mouseReceptors, Interleukin-7Transcription FactorsUbiquitin-Protein Ligases

Identifiers

PMID30674954
PMCPMC6344599
OpenAlexW2912411810

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.